000 01531 a2200433 4500
005 20250513091922.0
264 0 _c19960805
008 199608s 0 0 eng d
022 _a0022-1007
024 7 _a10.1084/jem.183.4.1357
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMayordomo, J I
245 0 0 _aTherapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.
_h[electronic resource]
260 _bThe Journal of experimental medicine
_cApr 1996
300 _a1357-65 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aBase Sequence
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aHistocompatibility Antigens Class I
_xmetabolism
650 0 4 _aMolecular Sequence Data
650 0 4 _aPeptide Fragments
_xgenetics
650 0 4 _aProtein Binding
650 0 4 _aSarcoma, Experimental
_xtherapy
650 0 4 _aTumor Suppressor Protein p53
_xgenetics
650 0 4 _aVaccination
700 1 _aLoftus, D J
700 1 _aSakamoto, H
700 1 _aDe Cesare, C M
700 1 _aAppasamy, P M
700 1 _aLotze, M T
700 1 _aStorkus, W J
700 1 _aAppella, E
700 1 _aDeLeo, A B
773 0 _tThe Journal of experimental medicine
_gvol. 183
_gno. 4
_gp. 1357-65
856 4 0 _uhttps://doi.org/10.1084/jem.183.4.1357
_zAvailable from publisher's website
999 _c8665199
_d8665199